These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15075903)

  • 1. Targeted therapies in the treatment of non small cell lung cancer: reality and hopes.
    Gridelli C
    Curr Opin Oncol; 2004 Mar; 16(2):126-9. PubMed ID: 15075903
    [No Abstract]   [Full Text] [Related]  

  • 2. [Targeted therapies. New hopes, new challenges].
    Barlési F
    Rev Mal Respir; 2008 Jun; 25(6):661-2. PubMed ID: 18772823
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeted therapies in non-small cell lung cancer: proven concepts and unfulfilled promises.
    Auberger J; Loeffler-Ragg J; Wurzer W; Hilbe W
    Curr Cancer Drug Targets; 2006 Jun; 6(4):271-94. PubMed ID: 16848720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapies in lung cancer.
    Besse B; Ropert S; Soria JC
    Ann Oncol; 2007 Jul; 18 Suppl 9():ix135-42. PubMed ID: 17631566
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical targeting of VEGF and EGFR effective in non-small cell lung cancer.
    Cancer Biol Ther; 2004 Jul; 3(7):588-9. PubMed ID: 15751163
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidermal growth factor receptor inhibitors and antiangiogenic agents for the treatment of non-small cell lung cancer.
    Horn L; Sandler A
    Clin Cancer Res; 2009 Aug; 15(16):5040-8. PubMed ID: 19671872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New therapies for non-small cell lung cancer].
    Ostoros G; Kovács G; Szondy K; Döme B
    Orv Hetil; 2005 May; 146(21):1135-41. PubMed ID: 15991677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of anti-angiogenesis in non-small-cell lung cancer: an update.
    Villaruz LC; Socinski MA
    Curr Oncol Rep; 2015 Jun; 17(6):26. PubMed ID: 25947099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Not Available].
    López-Brea M
    Med Clin (Barc); 2016 Apr; 146 Suppl 1():1. PubMed ID: 27426240
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeted therapies for advanced non-small-cell lung cancer: current status and future implications.
    Custodio A; Méndez M; Provencio M
    Cancer Treat Rev; 2012 Feb; 38(1):36-53. PubMed ID: 21592673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapies in lung cancer.
    Pirker R; Filipits M
    Curr Pharm Des; 2009; 15(2):188-206. PubMed ID: 19149612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel targeted approaches in non-small cell lung cancer (NSCLC).
    Ardizzoni A; Tiseo M
    Ann Oncol; 2006 May; 17 Suppl 5():v91-3. PubMed ID: 16807473
    [No Abstract]   [Full Text] [Related]  

  • 13. Time for molecularly targeted maintenance therapy for non-small-cell lung cancer?
    Stinchcombe TE; Ramalingam SS
    Lancet Oncol; 2010 Jun; 11(6):500-1. PubMed ID: 20493770
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeted therapy for the treatment of non-small cell lung cancer: focus on inhibition of epidermal growth factor receptor.
    Harichand-Herdt S; Ramalingam SS
    Semin Thorac Cardiovasc Surg; 2008; 20(3):217-23. PubMed ID: 19038731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label uses of bevacizumab: breast and lung cancer indications.
    Technol Eval Cent Assess Program Exec Summ; 2006 Oct; 21(8):1-4. PubMed ID: 17061398
    [No Abstract]   [Full Text] [Related]  

  • 16. [Promising targeted molecular therapies for the future years in non-small-cell lung cancer].
    Soria JC
    Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S35-6. PubMed ID: 16719155
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of targeted agents in the treatment of elderly patients with non-small cell lung cancer (NSCLC).
    Owonikoko TK; Ramalingam S
    Curr Treat Options Oncol; 2008 Dec; 9(4-6):313-25. PubMed ID: 18998213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic Inhibition of Thalidomide and Icotinib on Human Non-Small Cell Lung Carcinomas Through ERK and AKT Signaling.
    Sun X; Xu Y; Wang Y; Chen Q; Liu L; Bao Y
    Med Sci Monit; 2018 May; 24():3193-3203. PubMed ID: 29763936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAPK pathway: a potential target for the treatment of non-small-cell lung carcinoma.
    Pradhan R; Singhvi G; Dubey SK; Gupta G; Dua K
    Future Med Chem; 2019 Apr; 11(8):793-795. PubMed ID: 30994024
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional Inhibition of VEGF and EGFR Suppressors in Cancer Treatment.
    Nayarisseri A; Singh SK
    Curr Top Med Chem; 2019; 19(3):178-179. PubMed ID: 30950335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.